Background
Influenza virus is a single-stranded RNA virus, segmented, 70nm in diameter and enveloped. Strains are described by geographic origin, strain number, year of isolation and hemagglutination (H) and neuraminidase (N) antigens.

Source

Immunogen: Influenza B virions, Yamagata strain.

Product

Product Form: Unconjugated

Formulation: Supplied in PBS buffer, pH 7.5 with 0.1% Na Azide.

Purification Method: Purified IgG fraction, ~95% pure.

Purity: Purified

Concentration: See vial for concentration

Applications
Immunofluorescence: 1:500; Optimal concentration should be evaluated by serial dilutions.

Positive Control: Recognizes Influenza B virions. Does not react to Influenza A, RSV or Parainfluenza viruses.

Storage
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and store at -20°C

Product Stability: See expiration date on vial

Shipping Conditions: Ship at ambient temperature, freeze upon arrival

Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.

Safety Datasheet(s) for this product:
EA_Sodium Azide EA_Glycerol